has tirzepatide been approved by the fda ban on compounded tirzepatide: Switch to name brand medications What is the latest update

The overall outlook shows positive but moderate growth for 2026

While some Medicare Advantage plans offered by Aetna might have supplemental benefits, coverage for Zepbound for weight loss alone is highly unlikely under current Medicare rules

Paunel Vukasinov, MD, internist and obesity medicine specialist with Medical Offices of Manhattan, offers his opinion on the concerns with compounded versions of semaglutide

An injection session lasts around 30 minutes and is called an infusion

Semaglutide for weight loss is not recommended for patients with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or certain other medical conditions

Gramlich, for his part, surrendered his pharmacy license in 2025 and, according to public reporting and board records, agreed to wait at least three years before seeking reinstatement and to reimburse nearly $60,000 to cover the pharmacy boards investigation costs